Literature DB >> 12409006

Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse.

Melinda Wüst1, Beate Averbeck, Silke Reif, Manfred Bräter, Ursula Ravens.   

Abstract

Direct comparison of experimental data for drugs commonly used in the treatment of overactive bladder is difficult because of possible species differences. In this study, we compare the effects of atropine, propiverine, oxybutynin and tolterodine in strips of pig, guinea pig and mouse detrusor muscle. In the three species, we observed slight differences in potency of carbachol-induced biphasic contractile responses between the species (guinea pig>pig>mouse). Cumulative concentration-response curves for carbachol were shifted to the right by atropine, propiverine, oxybutynin and tolterodine. However, at higher concentrations of the latter three antagonists, the maximum response to carbachol was also reduced. Therefore, propiverine, oxybutynin and tolterodine must have additional pharmacological actions beyond competitive antagonism at muscarinic receptors. Electric field stimulation (30 Hz) of detrusor strips led to contraction amplitudes, which remained constant over time (210 min) in pig, decreased by 17+/-5% in guinea pig, and increased by 28+/-9% in mouse detrusor muscle. Electric field stimulation-evoked contractions were suppressed to 18% of pre-drug control by high concentrations of atropine (10 microM) in pig, but to a much lesser extent in guinea pig and mouse (to 46% and 70%, respectively). In all three species, a myogenic component of contraction was observed in the presence of tetrodotoxin (1 microM). Compared to atropine, the bladder spasmolytic agents propiverine, oxybutynin and tolterodine also reduced electrically evoked contractions in the three species, though higher concentrations were required. The differences in the reported effects of the spasmolytic agents commonly used for treating overactive bladder suggest that drug action is strongly dependent on the species. Thus, a comparison of drug effects is only feasible in the same animal model and the results cannot easily be transferred to humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409006     DOI: 10.1016/s0014-2999(02)02478-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Muscarinic receptor expression and receptor-mediated detrusor contraction: comparison of juvenile and adult porcine tissue.

Authors:  Melinda Wuest; Birgit Eichhorn; Manfred Braeter; Gerhard Strugala; Martin C Michel; Ursula Ravens
Journal:  Pflugers Arch       Date:  2007-12-21       Impact factor: 3.657

2.  Anticholinergic effects of cis- and trans-isomers of two metabolites of propiverine.

Authors:  Stefan Propping; Manfred Braeter; Marc-Oliver Grimm; Manfred P Wirth; Ursula Ravens; Melinda Wuest
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-02-25       Impact factor: 3.000

3.  Propiverine and metabolites: differences in binding to muscarinic receptors and in functional models of detrusor contraction.

Authors:  Melinda Wuest; Anke Weiss; Magali Waelbroeck; Manfred Braeter; Lutz-Ullrich Kelly; Oliver W Hakenberg; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-20       Impact factor: 3.000

4.  Spontaneous synaptic drive in detrusor smooth muscle: computational investigation and implications for urinary bladder function.

Authors:  Nilapratim Sengupta; Rohit Manchanda
Journal:  J Comput Neurosci       Date:  2019-11-12       Impact factor: 1.621

5.  Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction.

Authors:  Melinda Wuest; Juliane Hecht; Torsten Christ; Manfred Braeter; Christian Schoeberl; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

Review 7.  Purinoceptors as therapeutic targets for lower urinary tract dysfunction.

Authors:  Anthony P D W Ford; Joel R Gever; Philip A Nunn; Yu Zhong; Joseph S Cefalu; Michael P Dillon; Debra A Cockayne
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 8.  Electrophysiology of Syncytial Smooth Muscle.

Authors:  Rohit Manchanda; Shailesh Appukuttan; Mithun Padmakumar
Journal:  J Exp Neurosci       Date:  2019-01-17

9.  A Novel in situ Approach to Studying Detrusor Smooth Muscle Cells in Mice.

Authors:  Tamara Serdinšek; Saša Lipovšek; Gerd Leitinger; Igor But; Andraž Stožer; Jurij Dolenšek
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.